Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Study warns that potential epigenetic therapy may boost lung cancer stem cells

Study warns that potential epigenetic therapy may boost lung cancer stem cells

Epigenetic therapies — targeting enzymes that alter what genes are turned on or off in a cell — are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant. Researchers at Boston Children’s Hospital now report that at least one epigenetic therapy that initially looked promising for lung cancer actually has the opposite effect, boosting cancer stem cells that are believed to drive tumors. They also identify a strategy that reduces these cells, curbing lung cancer in mice.

Findings were published online today in Nature Communications.

Cancer stem cells have been identified in blood cancers and a variety of solid tumors. They make up a tiny fraction of tumor cells, but can regenerate a cancer on their own. Carla Kim, PhD, and colleagues in Boston Children’s Hospital’s Stem Cell Research program have shown that cancer stem cells play a role in adenocarcinoma, the most common type of lung cancer. When they transplanted cancer stem cells from a diseased mouse, previously healthy mice developed lung cancer.

The new study, led by lab member Samuel Rowbotham, PhD, looked at an epigenetic therapy that inhibits the enzyme G9a, a type of histone methyltransferase. G9a had been thought to be cancer-promoting, and some studies have suggested that inhibiting G9a is an effective strategy in certain cancers, including adenocarcinoma. Rowbotham and Kim now call this into question.

“People had looked at cell lines from lung tumors and found that they are sensitive to drugs inhibiting G9a,” says Rowbotham, first author on the paper. “In general tumor cell populations, these drugs would slow down growth or even kill the cells. But we found that these drugs were also making the surviving tumor cells more stem-like. We predicted that this would advance disease progression, and this is what we saw.”

The team first looked at adenocarcinoma cell lines and found that when the cells were treated with G9a, they became more like stem cells. They then transplanted cancer stem cells into live mice and tracked the development of adenocarcinoma. When they knocked down the G9a gene in lung tumors, the tumors grew bigger and spread farther.

Kim believes this down side to G9a hadn’t been noticed because prior studies only looked at cell lines, and because cancer stem cells are hard to detect.

“Earlier studies couldn’t see that cancer stem cells were still around, and there’s more of them when you treat with these drugs,” she says. “Because they’re such a small fraction of the tumor, anything that affects them can easily be missed.”

A new epigenetic target?

But Rowbotham, Kim and colleagues also found potentially better enzymes to target: Histone demethylases. Their action is chemically opposite to that of G9a, stripping off a methyl group from histone where G9a adds one. When Rowbotham knocked down the gene for demethylase enzymes, and added drug that prevents them from working, he was able to make the cells look less like cancer stem cells in a dish and behave less like cancer stem cells in live mice. When he gave demethylase inhibitors to mice with established lung tumors, cancer progression was slowed and the animals survived longer than untreated mice.

Although a cancer stem cell hasn’t been found in human adenocarcinoma, Kim believes the findings are worth pursuing further. She notes a related line of evidence — a 2017 study that found that demethylase inhibitors were effective in killing chemotherapy-resistant cells from patient tumors.

“Even if we can’t pinpoint cancer stem cells in human patients, Sam’s work shows you can start by studying a cancer stem cell in a mouse model and identify targets that could be clinically important,” she says. “It shows the importance of finding the right molecule the cancer is sensitive to. In adenocarcinoma, a demethylase inhibitor is likelier to be more useful than methyltransferase inhibitor.”

They and others envision a two-phase strategy for adenocarcinoma that would first target the general population of cancer cells to “debulk” the tumor, then add a second treatment specifically directed at cancer stem cells.

The team is now doing further studies to explore demethylase inhibitors as potential therapeutic drugs, alone or in combination with other treatments. Because demethylase inhibitors have very broad effects, they will also look for genes the inhibitors affect downstream, which could provide more specific drug targets.

Source:

http://www.childrenshospital.org/

Tagged with:

About author

Related Articles